DRIVEN TO CURE

“Our mission is to bring awareness and funding to support the research of rare kidney cancers like HLRCC in children and young adults.”

—Andrew Lee, Founder, Driven To Cure

Andrew Lee founded Driven To Cure at age 19, following his diagnosis with stage 4 HLRCC Kidney Cancer. Shortly after his diagnosis, Andrew decided to use his passion for cars to raise awareness about rare kidney cancers. Andrew founded Driven To Cure and—along with his family and friends—spent his remaining years travelling the country in his bright orange Nissan GTR; sharing hope and an awe-inspiring vehicle with young people battling cancer while raising both awareness of rare kidney cancers and funds to support research and the search for a cure. Andrew died peacefully on April 21, 2019, surrounded by those he loved.

Andrew was succeeded by his father Bruce, who took over as Driven To Cure’s President and CEO. Bruce spent the next four years growing the organization into a leading global provider of resources about HLRCC and other rare kidney cancers. Heartbreakingly, Bruce lost his own battle with cancer in December of 2022.

“Andrew and Bruce were so passionate about Driven To Cure. I recognize our next phase will be different without their unique gifts. But—having lost both my husband and a son to cancer—I am more committed than ever. We aren’t going anywhere. Thank you for joining us as we continue this work.”

—Sarah Lee, Board Member, Driven To Cure

As a 501(c)(3) nonprofit organization, Driven to Cure’s mission is to bring awareness and provide funding for the research of rare kidney cancers in children and young adults. Since its founding in 2016, Driven to cure has donated more than 1,100,000.00 to the NIH Foundation, the UCLA Foundation and other leading institutions focused on finding a cure for HLRCC and other rare kidney cancers.